Skip to main content

Advertisement

Log in

The combination of preoperative PET/CT and sentinel lymph node biopsy in the surgical management of early-stage cervical cancer

  • Original Article – Clinical Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Introduction

The aim of the study was to evaluate the use of PET/CT and/or SLN mapping alone or in combination in cervical cancer patients.

Materials and methods

Data on stage IA1-IIA cervical cancer patients undergoing PET/CT and SLN mapping were retrospectively collected. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of PET/CT and SLN mapping, alone or in combination, in identifying cervical cancer patients with lymph node metastases were calculated.

Results

Sixty patients met the inclusion criteria. PET/CT showed a sensitivity of 68%, a specificity of 84%, a PPV of 61% and a NPV of 88% in detecting lymph nodal metastases. SLN mapping showed a sensitivity of 93%, a specificity of 100%, a PPV of 100% and a NPV of 97%. The combination of PET/CT and SLN mapping showed a sensitivity of 100%, a specificity of 86%, a PPV of 72% and a NPV of 100%. For patients with tumors of >2 cm in diameter, the PET/CT showed a sensitivity of 68%, a specificity of 72%, a PPV of 61% and a NPV of 86%. SLN mapping showed a sensitivity of 93%, a specificity of 100%, a PPV of 100% and a NPV of 95%. The combination of PET/CT and SLN mapping showed a sensitivity of 100%, a specificity of 76%, a PPV of 72% and a NPV of 100%.

Conclusion

PET/CT represents a “safety net” that helps the surgeon in identifying metastatic lymph nodes, especially in patients with larger tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Altgassen C, Hertel H, Brandstädt A, Köhler C, Dürst M, Schneider A (2008) AGO Study Group. Multicenter validation study of the sentinel lymph node concept in cervical cancer. J Clin Oncol 26:2943–2951

    Article  PubMed  Google Scholar 

  • Bese T, Sal V, Demirkiran F, Kahramanoglu I, Tokgozoglu N, Ilvan S et al (2016) The combination of preoperative fluorodeoxyglucose positron emission tomography/computed tomography and sentinel lymph node mapping in the surgical management of endometrioid endometrial cancer. Int J Gynecol Cancer 26:1228–1238

    Article  PubMed  Google Scholar 

  • Buda A, Papadia A, Zapardiel I, Vizza E, Ghezzi F, De Ponti E (2016) From conventional radiotracer Tc-99(m) with blue dye to indocyanine green fluorescence: a comparison of methods towards optimization of sentinel lymph node mapping in early stage cervical cancer for a laparoscopic approach. Ann Surg Oncol 23:2959–2965

    Article  PubMed  Google Scholar 

  • Choi HJ, Ju W, Myung SK, Kim Y (2010) Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis. Cancer Sci 101:1471–1479

    Article  CAS  PubMed  Google Scholar 

  • Cormier B, Diaz JP, Shih K, Sampson RM, Sonoda Y, Park KJ et al (2011) Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer. Gynecol Oncol 122:275–280

    Article  PubMed  PubMed Central  Google Scholar 

  • Crivellaro C, Signorelli M, Guerra L, De Ponti E, Buda A, Dolci C et al (2012) 18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer. Gynecol Oncol 127:131–135

    Article  PubMed  Google Scholar 

  • Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F (1990) Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 38:352–357

    Article  CAS  PubMed  Google Scholar 

  • Di Martino G, Crivellaro C, De Ponti E, Bussi D, Papadia A, Zapardiel I et al (2017) Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm). J Minim Invasive Gynecology. pii:S1553-4650(17)30305–9. doi:10.1016/j.jmig.2017.05.011

  • Imboden S, Papadia A, Nauwerk M, McKinnon B, Kollmann Z, Mohr S et al (2015) A comparison of radiocolloid and indocyanine green fluorescence imaging, sentinel lymph node mapping in patients with cervical cancer undergoing laparoscopic surgery. Ann Surg Oncol 22:4198–4203

    Article  PubMed  PubMed Central  Google Scholar 

  • Lécuru F, Mathevet P, Querleu D, Leblanc E, Morice P, Daraï E et al (2011) Bilateral negative sentinel nodes accurately predict absence of lymph nodal metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol 29:1686–1691

    Article  PubMed  Google Scholar 

  • Lukas R, Helena R, Jiri HM, Martin H, Petr S (2013) Current status of sentinel lymph node mapping in the management of cervical cancer. Expert Rev Anticancer Ther 13:861–870

    Article  CAS  PubMed  Google Scholar 

  • Matsuura Y, Kawagoe T, Toki N, Tanaka M, Kashimura M (2006) Longstanding complications after treatment for cancer of the uterine cervix: clinical significance of medical examination at 5 years after treatment. Int J Gynecol Cancer 16:294–297

    Article  CAS  PubMed  Google Scholar 

  • Meigs JV (1956) Radical hysterectomy with bilateral dissection of the pelvic lymph nodes for cancer of the cervix (the Wertheim, Reis, Clark, Wertheim-Meigs operation). Surg Clin N Am 1083–116

  • NCCN clinical practice guidelines in oncology (2016) Cervical cancer. Version 1.2017. https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf. Accessed 29 June 2017

  • Nogami Y, Banno K, Irie H, Iida M, Kisu I, Masugi Y et al (2015) The efficacy of preoperative positron emission tomography-computed tomography (PET-CT) for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it. Jpn J Clin Oncol 45:26–34

    Article  PubMed  Google Scholar 

  • Papadia A, Imboden S, Gasparri ML, Siegenthaler F, Fink A, Mueller MD (2016a) Endometrial and cervical cancer patients with multiple sentinel lymph nodes at laparoscopic ICG mapping: how many are enough? J Cancer Res Clin Oncol 142:1831–1836

    Article  CAS  PubMed  Google Scholar 

  • Papadia A, Imboden S, Fink A, Gasparri ML, Bolla D, Mueller MD (2016b) Accuracy of sentinel lymph node mapping after previous hysterectomy in patients with occult cervical cancer. Ann Surg Oncol 23:2199–2205

    Article  PubMed  Google Scholar 

  • Papadia A, Imboden S, Siegenthaler F, Gasparri ML, Mohr S, Lanz S, Mueller MD (2016c) Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer. Annals of Surgical Oncology 23(7):2206–2211

  • Papadia A, Zapardiel I, Bussi B, Ghezzi F, Ceccaroni M, De Ponti E (2017) Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99(m) with blue dye versus indocyanine green fluorescent dye. J Cancer Res Clin Oncol 143:475–480

  • Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, Berek JS et al (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18:1606–1613

    Article  CAS  PubMed  Google Scholar 

  • Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI et al (2006) A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 65:169–176

    Article  PubMed  Google Scholar 

  • Ruscito I, Gasparri ML, Braicu EI, Bellati F, Raio L, Sehouli J (2016) Sentinel node mapping in cervical and endometrial cancer: indocyanine green versus other conventional dyes-A meta-analysis. Ann Surg Oncol 23:3749–3756

    Article  PubMed  Google Scholar 

  • Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ (1999) A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study. Gynecol Oncol 73:177–183

    Article  CAS  PubMed  Google Scholar 

  • Signorelli M, Crivellaro C, Buda A, Guerra L, Fruscio R, Elisei F et al (2015) Staging of high-risk endometrial cancer with PET/CT and sentinel lymph node mapping. Clin Nucl Med 40:780–785

    Article  PubMed  Google Scholar 

  • Yen TC, Lai CH, Ma SY, Huang KG, Huang HJ, Hong JH et al (2006) Comparative benefits and limitations of 18F-FDG PET and CT-MRI in documented or suspected recurrent cervical cancer. Eur J Nucl Med Mol Imaging 33:1399–1407

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrea Papadia.

Ethics declarations

Conflict of interest

All of the authors declare no conflict of interest.

Funding

This study was not supported by any funding.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. IRB approval was obtained.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Papadia, A., Gasparri, M.L., Genoud, S. et al. The combination of preoperative PET/CT and sentinel lymph node biopsy in the surgical management of early-stage cervical cancer. J Cancer Res Clin Oncol 143, 2275–2281 (2017). https://doi.org/10.1007/s00432-017-2467-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-017-2467-6

Keywords

Navigation